BioSpace News Archive

Pharmefex, Sync.MD and X-CELLSYSTEM, all U.S. companies based in the state of Washington, have formed an alliance to provide an urgently needed resource for our nation’s ability to Open Our Country.

Celavie Biosciences, LLC, a company working to improve lives and restore hope by advancing innovations in CNS diseases with regenerative stem cell-based therapies, today announced that the Company will give a corporate presentation at the April 2020 Virtual Investor Summit, taking place online from April 22-23, 2020.

Circulaire® ll Aerosol Drug Delivery System mitigates healthcare workers’ exposure to contagions like coronavirus, while optimizing medication delivery for patients*

General Motors Co. began mass production of the Ventec Life Systems V+Pro critical care ventilator under contract to the U.S. Department of Health and Human Services.

People with diabetes using Novo Nordisk Inc. insulin who have lost health insurance coverage because of a change in job status due to the COVID-19 pandemic may now be eligible for enrollment in our Diabetes Patient Assistance Program and receive insulin free of charge for 90 days..

Although Americans report feelings of unease and anxiety, they also express feelings of gratitude, hope, and resilience

Health Canada is warning Canadians about the risks of using fraudulent and unauthorized N95 respirators, as they may not protect consumers against COVID-19.

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results for the first quarter ended March 31, 2020, after the close of the stock market on Thursday, April 23, 2020.

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Endologix, Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it has appointed Tim A. Benner to succeed John Zehren as the Company’s Chief Commercial Officer, effective as of April 14, 2020.